Temporary worsening of parkinsonism in a patient with Parkinson's disease after treatment with paclitaxel for a metastatic grade IV adenocarcinoma
β Scribed by James H. Bower; Manfred D. Muenter
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 232 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
roradiological features beyond the typical cerebellar peduncle hyperintensities that were found minimal in this instance. FXTAS is expected to be less severe in females because of the presence of two X chromosomes, subject to random inactivation. It has been suggested that expression of the disease
## Abstract Due to its low profile for extrapyramidal sideβeffects, quetiapine has become an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease (PD). We describe the case of a patient with PD who developed severe akathisia, a common complication
Freezing of gait (FOG) has been known to respond favorably to sensory tricks and cues. However, FOG is a complex phenomenon with various motor control deficits at play. In this review, we examined and summarized the currently available evidence for the effectiveness of cueing for FOG to determine it
## Abstract Underreporting of swallowing disturbances by Parkinson's disease (PD) patients may lead to delay in diagnosis and treatment, alerting the physician to an existing dysphagia only after the first episode of aspiration pneumonia. We developed and validated a swallowing disturbance question
## Abstract To assess the safety and efficacy of sumanirole, a highly selective dopamine agonist, versus placebo and demonstrate its noninferiority to ropinirole, 614 patients with early Parkinson's disease (PD) were treated with sumanirole, 1 to16 mg/day; ropinirole, 0.75 to 24 mg/day; or placebo.